GlassScriptPhysician profile
Michael P Barrett
NPI 1851334841
$1,813.94
in general payments reported to CMS, 2019-2025
20 companies · $612 in 2025
The $612 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $112 · 2021: $151 · 2022: $239 · 2023: $220 · 2024: $89.02 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.95 | 2023-2025 | Botox |
| Depuy Synthes Sales INC. | $227.77 | 2019-2025 | Orthovisc, Monovisc, Peak |
| Allergan, INC. | $210.05 | 2021-2022 | |
| Bioventus LLC | $206.08 | 2019-2021 | |
| Smith+Nephew, INC. | $116.80 | 2025 | Na, Lens 4k, N/A |
| Zimmer Biomet Holdings, INC. | $85.70 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Pacira Therapeutics, INC. | $85.42 | 2019 | |
| Sanofi-Aventis U.S. LLC | $71.40 | 2019-2023 | |
| Ossur Americas, INC. | $61.79 | 2025 | Unloader One X |
| Ferring Pharmaceuticals INC. | $51.52 | 2019-2021 | |
| Zyla Life Sciences, INC. | $33.52 | 2019 | |
| Stryker Corporation | $30.49 | 2019-2022 | |
| Ibsa Pharma INC. | $27.84 | 2021-2024 | Tirosint, Licart |
| Fidia Pharma USA INC. | $23.79 | 2023 | Hymovis |
| Orthogenrx INC. | $23.42 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $16.55 | 2022 | |
| Globus Medical, INC. | $15.87 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $15.76 | 2019 | |
| Vericel Corporation | $15.11 | 2023 | Maci |
| Pacira Pharmaceuticals Incorporated | $13.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.